<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Irbesartan slows progression of nephropathy in type 2 diabetes</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Irbesartan slows progression of nephropathy in type 2 diabetes</h1>
<div class="graphic"><div class="figure"><div class="ttl">Irbesartan slows progression of nephropathy in type 2 diabetes</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_lgnd">Effect of irbesartan, amlodipine, and placebo on the course of patients with hypertension with nephropathy due to type 2 diabetes; the target blood pressure was similar in the 3 groups. Treatment with irbesartan was associated with a risk of the primary end point (doubling of the baseline serum creatinine, development of end-stage kidney disease, or death from any cause) that was 20% lower than placebo and 23% lower than amlodipine.</div><div class="graphic_reference">Adapted from data published in: Lewis EJ, Hunsicker LG, Clarke WR, et al. N Engl J Med 2001; 345:851.</div><div id="graphicVersion">Graphic 80116 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
